Vincent Viviani was born in Paris (France), after spending 3 years in Tahiti (French Polynesia), he came back to France for College. He obtained in 2013 his B.S. in Chemistry and Biology (Pr. Rachid Barhdadi) from The Université Paris-EST Créteil (France). During his undergraduate studies, he worked to develop an induction model of Parkinson's Disease by the synthesis of pyridinium derivatives. In 2015, he obtained his M.S. in Chemistry of Bioactive Molecules (Pr. Sylvie Condon) at the same university where he worked in a pharmaceutical company, Sanofi, in the Chemical Development Department on the synthesis and development of cationic lipid nanoparticles for sRNA in vivo delivery. In 2017, he finished his M.Eng. in Chemical Engineering at Chimie Paris-Tech (ENSCP - France) (Pr. Christophe Thomas). Then he worked for one year in the Integrated Drug Discovery Department at Sanofi (France) where he worked on the synthesis of therapeutic targets over diverse fields (oncology, rare diseases, cardiovascular, ...). In August 2018, he joined the Hull Group at the University of Texas at Austin where he is studying transition metal-catalyzed allene difunctionalization reactions and total synthesis. Outside of the laboratory, Vincent enjoys being outside, swimming, learning about Texas History, and spending time with his friends.
Fellowship: Welch Foundation Fellowship
Awards: Henze Teaching Award (2021), Outstanding Teaching Assistant Award (2022)